MediWound(MDWD),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

MDWD MediWound

Trading 12-22 11:40:59 EST

19.00

+0.23

+1.23%

High19.30	Low18.80	Vol34.96K
Open18.86	D1 Closing18.77	Amplitude2.64%
Mkt Cap243.61M	Tradable Cap174.16M	Total Shares12.82M
T/O666.44K	T/O Rate0.38%	Tradable Shares9.17M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"MDWD","market":"US","secType":"STK","nameCN":"MediWound","latestPrice":19,"timestamp":1766421637969,"preClose":18.77,"halted":0,"volume":34955,"delay":0,"floatShares":9166095,"shares":12821433,"eps":-1.896383,"marketStatus":"Trading","change":0.23,"latestTime":"12-22 11:40:59 EST","open":18.86,"high":19.295,"low":18.8,"amount":666439.16656,"amplitude":0.026372,"askPrice":19.08,"askSize":161,"bidPrice":18.95,"bidSize":221,"shortable":3,"etf":0,"ttmEps":-1.896383,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1766437200000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1395288000000,"exchange":"NASDAQ","adjPreClose":18.77,"preHourTrading":{"tag":"盘前","latestPrice":18.81,"preClose":18.77,"latestTime":"08:10 EST","volume":113,"amount":2144.530046,"timestamp":1766409004248},"postHourTrading":{"tag":"盘后","latestPrice":18.77,"preClose":18.77,"latestTime":"17:36 EST","volume":74353,"amount":1395592.18,"timestamp":1766183761377},"volumeRatio":1.166763,"impliedVol":0.3398,"impliedVolPercentile":0.46},"requestUrl":"/m/hq/s/MDWD","defaultTab":"news","newsList":[{"id":"2590495581","title":"MediWound Study Finds NexoBrid Removes Over 90% of Traumatic Tattoo Pigments After Injuries","url":"https://stock-news.laohu8.com/highlight/detail?id=2590495581","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590495581?lang=en_us&edition=fundamental","pubTime":"2025-12-10 20:00","pubTimestamp":1765368022,"startTime":"0","endTime":"0","summary":"MediWound Ltd. has announced the publication of new prospective clinical data demonstrating the effectiveness of NexoBrid in removing embedded particles associated with traumatic tattoos following abrasion and blast injuries. The study, conducted at Sheba Medical Center's National Burn Center, included 15 patients who received NexoBrid treatment within 24 hours of injury after standard mechanical scrubbing. Results showed a reduction in mean pigmented wound area from 37.5% to 2.1%, representing a 92.5% decrease in pigmented wound surface compared to baseline after scrubbing. The treatment was well tolerated, with no treatment-related adverse events reported during the early post-procedure period. These findings have already been published in a peer-reviewed journal.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251210:nNDL3VVjbG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BKPKM429.USD","LU2210149790.SGD","NDAQ","SG9999014005.SGD","BK4007","BK4588","IE00B3QW5Z07.USD","BK4585","SG9999014021.USD","IE00B64PRP62.GBP","SG9999014039.USD","LU2095319765.USD","SG9999014013.SGD","IE00BGHQF748.EUR","LU0314104364.USD","BK4112","LU2210150020.SGD","MDWD"],"gpt_icon":0},{"id":"2585105074","title":"MediWound: Strong Financial Health and Market Opportunities Drive Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2585105074","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585105074?lang=en_us&edition=fundamental","pubTime":"2025-11-23 04:15","pubTimestamp":1763842513,"startTime":"0","endTime":"0","summary":"Maxim Group analyst Michael Okunewitch has maintained their bullish stance on MDWD stock, giving a Buy rating yesterday. Michael Okunewitch has giv...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/mediwound-strong-financial-health-and-market-opportunities-drive-buy-rating-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/mediwound-strong-financial-health-and-market-opportunities-drive-buy-rating-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MDWD"],"gpt_icon":0},{"id":"2585117860","title":"MediWound Is Maintained at Buy by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2585117860","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585117860?lang=en_us&edition=fundamental","pubTime":"2025-11-21 19:25","pubTimestamp":1763724300,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/MDWD/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 21, 2025 06:25 ET (11:25 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MDWD"],"gpt_icon":0},{"id":"2585112793","title":"MediWound price target raised to $36 from $31 at H.C. Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2585112793","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585112793?lang=en_us&edition=fundamental","pubTime":"2025-11-21 19:10","pubTimestamp":1763723436,"startTime":"0","endTime":"0","summary":"H.C. Wainwright raised the firm’s price target on MediWound (MDWD) to $36 from $31 and keeps a Buy rating on the shares. The company’s new manufact...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/mediwound-price-target-raised-to-36-from-31-at-h-c-wainwright-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/mediwound-price-target-raised-to-36-from-31-at-h-c-wainwright-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MDWD"],"gpt_icon":0},{"id":"2585112617","title":"Mediwound Ltd : H.c. Wainwright Raises Target Price to $36 From $31","url":"https://stock-news.laohu8.com/highlight/detail?id=2585112617","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585112617?lang=en_us&edition=fundamental","pubTime":"2025-11-21 19:08","pubTimestamp":1763723329,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251121:nFWN3WX0N1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MDWD","BK4007"],"gpt_icon":0},{"id":"2585690541","title":"MediWound’s Earnings Call: Growth Amid Challenges","url":"https://stock-news.laohu8.com/highlight/detail?id=2585690541","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585690541?lang=en_us&edition=fundamental","pubTime":"2025-11-21 08:06","pubTimestamp":1763683597,"startTime":"0","endTime":"0","summary":"Mediwound (($MDWD)) has held its Q3 earnings call. Read on for the main highlights of the call. MediWound’s recent earnings call presented a mixed ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/mediwounds-earnings-call-growth-amid-challenges?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/mediwounds-earnings-call-growth-amid-challenges?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MDWD"],"gpt_icon":0},{"id":"2584397071","title":"MediWound Announces Q3 2025 Financial Results and Facility Expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=2584397071","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584397071?lang=en_us&edition=fundamental","pubTime":"2025-11-20 20:27","pubTimestamp":1763641656,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Mediwound ( ($MDWD) ). On November 20, 2025, MediWound Ltd. announced its third-quarter financial results, high...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/mediwound-announces-q3-2025-financial-results-and-facility-expansion?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/mediwound-announces-q3-2025-financial-results-and-facility-expansion?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MDWD","BK4007"],"gpt_icon":0},{"id":"2584136738","title":"MediWound misses Q3 revenue estimates","url":"https://stock-news.laohu8.com/highlight/detail?id=2584136738","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584136738?lang=en_us&edition=fundamental","pubTime":"2025-11-20 20:08","pubTimestamp":1763640535,"startTime":"0","endTime":"0","summary":"MediWound misses Q3 revenue estimatesOverviewMediWound Q3 2025 revenue up 23% yr/yr but missed analyst expectationsAdjusted EBITDA loss for Q3 beats analyst estimatesCompany strengthens balance sheet ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251120:nL1N3WW0G7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MDWD","BK4007"],"gpt_icon":0},{"id":"2584136978","title":"MediWound Reports Q3 Revenue of $5.4 Million and Net Loss of $16.7 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2584136978","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584136978?lang=en_us&edition=fundamental","pubTime":"2025-11-20 20:00","pubTimestamp":1763640054,"startTime":"0","endTime":"0","summary":"MediWound Ltd. reported third quarter 2025 revenue of $5.4 million, an increase of 23% year-over-year. For the first nine months of 2025, the company recorded an operating loss of $17.5 million, compared to $13.3 million in the same period of 2024. Net loss for the period was $16.7 million, or $1.53 per share, down from $26.3 million, or $2.72 per share, in 2024, primarily due to non-cash financial income from warrant revaluation. Non-GAAP Adjusted EBITDA loss was $13.9 million, compared to a loss of $9.9 million in 2024. MediWound used $15.8 million in cash for operating activities during the first nine months of 2025 and ended September 30, 2025, with $60 million in cash, cash equivalents, and short-term deposits, up from $44 million at the end of 2024. Business developments included ongoing enrollment in the VALUE Phase III trial of EscharEx for venous leg ulcers and completion of commissioning for the expanded NexoBrid facility, with full operational capacity expected by year-end 2","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251120:nNDL6hHrYN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210150020.SGD","BK4112","LU2210149790.SGD","MDWD","LU2095319765.USD","IE00B64PRP62.GBP","IE00BGHQF748.EUR","IE00B3QW5Z07.USD","BK4588","LU0314104364.USD","BK4585","BK4007","NDAQ","IE00BKPKM429.USD"],"gpt_icon":0},{"id":"2584136993","title":"BRIEF-MediWound Q3 EPS USD -0.24","url":"https://stock-news.laohu8.com/highlight/detail?id=2584136993","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584136993?lang=en_us&edition=fundamental","pubTime":"2025-11-20 20:00","pubTimestamp":1763640047,"startTime":"0","endTime":"0","summary":"BRIEF-MediWound Q3 EPS USD -0.24\n\n\nNov 20 (Reuters) - MediWound Q3 revenue USD 5.4 million vs. IBES estimate USD 6.65 million.\n\nQ3 gross profit USD 900 thousand\nQ3 net income USD -2.7 million\nQ3 adjusted EBITDA USD -5.4 million\nQ3 operating income USD -6.5 million","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251120:nPLX9BE6A5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","MDWD"],"gpt_icon":0},{"id":"2584609136","title":"Mediwound Q3 Gross Profit USD 900 Thousand","url":"https://stock-news.laohu8.com/highlight/detail?id=2584609136","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584609136?lang=en_us&edition=fundamental","pubTime":"2025-11-20 20:00","pubTimestamp":1763640002,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251120:nPLX9BE6A5:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","MDWD"],"gpt_icon":0},{"id":"2584113660","title":"Mediwound Q3 Operating Income USD -6.5 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2584113660","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584113660?lang=en_us&edition=fundamental","pubTime":"2025-11-20 20:00","pubTimestamp":1763640002,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251120:nPLX9BE6A5:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MDWD","BK4007"],"gpt_icon":0},{"id":"2584136216","title":"MediWound Reports Third Quarter 2025 Financial Results and Provides Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2584136216","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584136216?lang=en_us&edition=fundamental","pubTime":"2025-11-20 20:00","pubTimestamp":1763640000,"startTime":"0","endTime":"0","summary":"Ongoing Enrollment Continues in VALUE Phase III Trial of EscharEx in Venous Leg Ulcers  Commissioning Completed for Expanded NexoBrid Facility; Full Operational Capacity Expected by Year-End 2025 Bala","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/20/3191754/30505/en/MediWound-Reports-Third-Quarter-2025-Financial-Results-and-Provides-Corporate-Update.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4213","TGA","BK4007","MDWD"],"gpt_icon":0},{"id":"2581247447","title":"MediWound Ltd. to Release Third Quarter 2025 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2581247447","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581247447?lang=en_us&edition=fundamental","pubTime":"2025-11-05 20:30","pubTimestamp":1762345811,"startTime":"0","endTime":"0","summary":"MediWound Ltd. will release its third quarter 2025 financial results on November 20, 2025. Following the release, the Company's management will host a conference call and live webcast at 8:30 a.m. Eastern Time. The webcast can be accessed at Webcast Link. An archived version will be available on the Investors section of the MediWound website.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. MediWound Ltd. published the original content used to generate this news brief via GlobeNewswire  on November 05, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251105:nNDL2dyGQx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","IE00B3QW5Z07.USD","BK4112","BK4585","LU0314104364.USD","LU2095319765.USD","IE00B64PRP62.GBP","IE00BGHQF748.EUR","BK4588","MDWD","LU2210149790.SGD","LU2210150020.SGD","NDAQ","IE00BKPKM429.USD"],"gpt_icon":0},{"id":"2581766204","title":"MediWound’s Strategic Expansion and NexoBrid’s Market Potential Drive Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2581766204","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581766204?lang=en_us&edition=fundamental","pubTime":"2025-11-05 04:45","pubTimestamp":1762289111,"startTime":"0","endTime":"0","summary":"Mediwound, the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Michael Okunewitch from Maxim Group maintained ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/mediwounds-strategic-expansion-and-nexobrids-market-potential-drive-buy-rating-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/mediwounds-strategic-expansion-and-nexobrids-market-potential-drive-buy-rating-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MDWD"],"gpt_icon":0},{"id":"2580213525","title":"MediWound Boosts NexoBrid Production Capacity Sixfold","url":"https://stock-news.laohu8.com/highlight/detail?id=2580213525","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580213525?lang=en_us&edition=fundamental","pubTime":"2025-11-03 21:01","pubTimestamp":1762174906,"startTime":"0","endTime":"0","summary":"MediWound Ltd., a global leader in enzymatic therapeutics for tissue repair, has successfully completed the commissioning of its expanded GMP manufacturing facility in Yavne, Israel. The expansion marks a significant step toward increasing production capacity for its burn treatment product, NexoBrid, by approximately sixfold. The facility is expected to be fully operational by the end of 2025, positioning MediWound to meet growing global demand and ensure a reliable supply of NexoBrid in over 40 approved markets, pending regulatory review.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. MediWound Ltd. published the original content used to generate this news brief via GlobeNewswire  on November 03, 2025, and is solely responsible for th","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251103:nNDL23g94n:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MDWD","LU2210149790.SGD","LU0314104364.USD","NDAQ","BK4588","BK4112","LU2210150020.SGD","IE00B3QW5Z07.USD","IE00BGHQF748.EUR","IE00BKPKM429.USD","IE00B64PRP62.GBP","BK4007","BK4585","LU2095319765.USD"],"gpt_icon":0},{"id":"2578624604","title":"MediWound’s EscharEx Study: A Potential Game-Changer for Venous Leg Ulcers","url":"https://stock-news.laohu8.com/highlight/detail?id=2578624604","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578624604?lang=en_us&edition=fundamental","pubTime":"2025-10-28 01:53","pubTimestamp":1761587614,"startTime":"0","endTime":"0","summary":"Mediwound (($MDWD)) announced an update on their ongoing clinical study. Study Overview: The clinical study titled A Multicenter, Prospective, Rand...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/mediwounds-escharex-study-a-potential-game-changer-for-venous-leg-ulcers?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/mediwounds-escharex-study-a-potential-game-changer-for-venous-leg-ulcers?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MDWD","BK4007"],"gpt_icon":0},{"id":"2571286593","title":"Craig-Hallum Reaffirms Their Buy Rating on Mediwound (MDWD)","url":"https://stock-news.laohu8.com/highlight/detail?id=2571286593","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571286593?lang=en_us&edition=fundamental","pubTime":"2025-09-30 20:56","pubTimestamp":1759236989,"startTime":"0","endTime":"0","summary":"Craig-Hallum analyst Chase Knickerbocker maintained a Buy rating on Mediwound today. The company’s shares closed yesterday at $17.97. According to ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/craig-hallum-reaffirms-their-buy-rating-on-mediwound-mdwd-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/craig-hallum-reaffirms-their-buy-rating-on-mediwound-mdwd-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MDWD"],"gpt_icon":0},{"id":"2571331727","title":"MediWound Prices $30 Million Registered Direct Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2571331727","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571331727?lang=en_us&edition=fundamental","pubTime":"2025-09-29 21:44","pubTimestamp":1759153459,"startTime":"0","endTime":"0","summary":"MediWound  said Monday that it has priced a $30 million registered direct offering of 1.73 million ordinary shares at $17.30 each.The company said it plans to use the net proceeds from the offering, which is expected to close Tuesday, to fund pre-commercial activities for EscharEx, expand large-scale manufacturing, and for general corporate purposes.Price: 17.96, Change: +0.07, Percent Change: +0.39","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MDWD","BK4007"],"gpt_icon":0},{"id":"2571833974","title":"MediWound Announces $30 Million Direct Offering to Boost Operations","url":"https://stock-news.laohu8.com/highlight/detail?id=2571833974","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571833974?lang=en_us&edition=fundamental","pubTime":"2025-09-29 21:19","pubTimestamp":1759151965,"startTime":"0","endTime":"0","summary":"Mediwound ( ($MDWD) ) has shared an announcement. On September 29, 2025, MediWound Ltd. announced a $30 million registered direct offering of ordin...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/mediwound-announces-30-million-direct-offering-to-boost-operations?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/mediwound-announces-30-million-direct-offering-to-boost-operations?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","MDWD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.mediwound.com","stockEarnings":[{"period":"1week","weight":-0.0147},{"period":"1month","weight":0.051},{"period":"3month","weight":0.1054},{"period":"6month","weight":-0.0168},{"period":"1year","weight":0.0913},{"period":"ytd","weight":0.0545}],"compareEarnings":[{"period":"1week","weight":-0.0017},{"period":"1month","weight":0.0271},{"period":"3month","weight":0.0254},{"period":"6month","weight":0.1452},{"period":"1year","weight":0.1612},{"period":"ytd","weight":0.1613}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in United States, Europe, and internationally. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. The company also develops EscharEx, which has completed Phase II clinical trials for the debridement of chronic and other hard-to-heal wounds; MW005, which is in phase I/II for the treatment of low-risk basal cell carcinoma. MediWound Ltd. was incorporated in 2000 and is headquartered in Yavne, Israel.","yearOnYearQuotes":[{"month":1,"riseRate":0.727273,"avgChangeRate":0.114505},{"month":2,"riseRate":0.454545,"avgChangeRate":-0.013432},{"month":3,"riseRate":0.454545,"avgChangeRate":-0.01746},{"month":4,"riseRate":0.583333,"avgChangeRate":0.006287},{"month":5,"riseRate":0.5,"avgChangeRate":-0.012335},{"month":6,"riseRate":0.5,"avgChangeRate":0.0451},{"month":7,"riseRate":0.25,"avgChangeRate":-0.023236},{"month":8,"riseRate":0.416667,"avgChangeRate":-0.022019},{"month":9,"riseRate":0.5,"avgChangeRate":-0.016529},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.053412},{"month":11,"riseRate":0.5,"avgChangeRate":0.011619},{"month":12,"riseRate":0.5,"avgChangeRate":-0.017145}],"exchange":"NASDAQ","name":"MediWound","nameEN":"MediWound"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"MediWound(MDWD),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest MediWound(MDWD) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"MediWound,MDWD,MediWound股票,MediWound股票老虎,MediWound股票老虎国际,MediWound行情,MediWound股票行情,MediWound股价,MediWound股市,MediWound股票价格,MediWound股票交易,MediWound股票购买,MediWound股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"MediWound(MDWD),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest MediWound(MDWD) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction